Connection

Jacques Izopet to Anti-Retroviral Agents

Back to Details
This is a "connection" page, showing publications Jacques Izopet has written about Anti-Retroviral Agents.
Jacques Izopet
Connection Strength
0.122
Anti-Retroviral Agents
  1. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. J Antimicrob Chemother. 2018 03 01; 73(3):738-747.
    View in: PubMed
    Score: 0.096
  2. Increased CXCR3+ T Cells Impairs Recruitment of T-Helper Type 17 Cells via Interferon ? and Interleukin 18 in the Small Intestine Mucosa During Treated HIV-1 Infection. J Infect Dis. 2019 07 31; 220(5):830-840.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.